Immunovant
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immunovant and other ETFs, options, and stocks.About IMVT
Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It develops a novel, fully human monoclonal antibody, IMVT-1401, which selectively binds to and inhibits the neonatal fragment crystallizable receptor.
IMVT Key Statistics
Stock Snapshot
Immunovant(IMVT) stock is priced at $39.81, giving the company a market capitalization of 8.23B. It carries a P/E multiple of -13.97.
During the trading session on 2026-09-08, Immunovant(IMVT) shares reached a daily high of $40.56 and a low of $38.34. At a current price of $39.81, the stock is +3.8% higher than the low and still -1.8% under the high.
Trading volume for Immunovant(IMVT) stock has reached 490.71K, versus its average volume of 1.16M.
The stock's 52-week range extends from a low of $14.58 to a high of $45.42.
The stock's 52-week range extends from a low of $14.58 to a high of $45.42.
Analyst ratings
76%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.